Answers are grounded in this paper and cite their sources.
In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy. (Funded by Gilead Sciences.).
No takes yet. Share an insight, caveat, or question.
Grein et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: